{"id":"W4298147309","doi":"10.1200/jco.2022.40.28_suppl.013","title":"Medicare coverage and cost-sharing for abiraterone following generic entry.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Conquer Cancer Foundation","keywords":"Medicine; Beneficiary; Formulary; Medicare Part D; Cost sharing; Prescription drug; Market share; Generic drug; Product (mathematics); Competition (biology); Medical prescription; Marketing; Business; Family medicine; Drug; Finance; Pharmacology; Mathematics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00215483,0.0002824124,0.000299427,0.001649819,0.0003754726,0.0009374677,0.0005571417,0.0006104963,0.005505571],"category_scores_gemma":[0.01194107,0.0001990392,0.001414122,0.002731313,0.0003081817,0.0008312247,0.0008854531,0.0008202931,0.00038748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003326292,"about_ca_system_score_gemma":0.001678694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.035576,"about_ca_topic_score_gemma":0.03019172,"domain_scores_codex":[0.997872,0.0005492018,0.0002100477,0.0002589885,0.0006466859,0.0004631043],"domain_scores_gemma":[0.9911256,0.001792202,0.005578152,0.0003073878,0.0005777042,0.0006188411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007490751,0.0001168677,0.9805043,0.00009590694,0.0002874536,0.0001870926,0.0001070862,0.00242746,0.0001238424,0.0009669064,0.004384787,0.01004918],"study_design_scores_gemma":[0.00005759151,0.000138625,0.9911826,0.00005495415,0.000131378,0.0003870202,0.0001176773,0.003999664,0.000106685,0.0003860848,0.00342528,0.0000124861],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9549143,0.001385146,0.0004899856,0.0008431787,0.00002801187,0.0001548974,0.03488426,0.00003917073,0.007261078],"genre_scores_gemma":[0.9883103,0.0001794,0.0002844568,0.0001666297,0.00003110885,0.00006700181,0.01031965,0.000006691627,0.0006346904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.035576,"threshold_uncertainty_score":0.07073784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2614241358421591,"score_gpt":0.450878591896307,"score_spread":0.1894544560541479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}